with A2 and A2B may have anti-A1 antibodies that may be clinically significant or
insignificant. The aim of this study was to determine the frequency of A2, A2B phenotypes
and anti-A1 antibodies in blood donors in Jazan, Saudi Arabia. This study also evaluated
the reactivity potential of anti-A1 antibodies. Materials and Methods Blood samples collected
from 446 blood donors were typed for ABO (cell and serum grouping) and Rh D. Individuals …